These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15831617)

  • 21. Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review.
    Tam VH; Mckinnon PS; Levine DP; Brandel SM; Rybak MJ
    Pharmacotherapy; 2000 Sep; 20(9):1116-9. PubMed ID: 10999505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
    Working P
    Heart; 1998 Feb; 79(2):207-10. PubMed ID: 9538323
    [No Abstract]   [Full Text] [Related]  

  • 23. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
    Schwank S; Blaser J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2258-61. PubMed ID: 8891125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
    Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
    Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
    Fantin B; Carbon C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2387-91. PubMed ID: 2128443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P; Brandimarte C; Martino P; Carlone S; Giunchi G
    Arch Intern Med; 1977 Nov; 137(11):1562-7. PubMed ID: 921443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
    Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of netilmicin and gentamicin in the treatment of pelvic infections.
    Schnider G; Birken RA; Poindexter AN
    Obstet Gynecol; 1979 Nov; 54(5):554-7. PubMed ID: 503379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Netilmicin in refractory urinary tract infections. Good therapeutic effect in spite of long dosage intervals].
    Brunner FP; Wenk M; Mauracher E; Thiel G; Follath F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):934-41. PubMed ID: 7112061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillin and netilmicin in treatment of experimental enterococcal endocarditis.
    Carrizosa J; Kaye D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):505-8. PubMed ID: 122526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside-containing antibiotic combinations for the treatment of bacterial endocarditis: an evidence-based approach.
    Leibovici L
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S46-9. PubMed ID: 21130606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enterococcal endocarditis, a model of therapeutic difficulty].
    Fernández Guerrero ML; Núñez García A
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
    [No Abstract]   [Full Text] [Related]  

  • 36. Gentamicin-resistant enterococcal endocarditis: the need for routine screening for high-level resistance to aminoglycosides.
    Libertin CR; McKinley KM
    South Med J; 1990 Apr; 83(4):458-60. PubMed ID: 2108503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of linezolid treatment for enterococcal endocarditis.
    Zimmer SM; Caliendo AM; Thigpen MC; Somani J
    Clin Infect Dis; 2003 Aug; 37(3):e29-30. PubMed ID: 12884185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis and treatment of enterococcal infections.
    Gross MH; Barriere SL
    Clin Pharm; 1984; 3(2):161-6. PubMed ID: 6373101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Enterococcus endocarditis model in experimental animals and its relevance to human infection.
    Gutschik E
    J Antimicrob Chemother; 1993 May; 31 Suppl D():87-95. PubMed ID: 8335527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial therapy for two serious bacterial infections. Enterococcal endocarditis and nosocomial pneumonia.
    Sande MA
    Arch Intern Med; 1982 Oct; 142(11):2033-4. PubMed ID: 7125791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.